What you need to know about the new direct marketing guidance note
Nadine Mather and Chloë Loubser
Test phase shows malaria vaccine 100% effective
Clinical trials for the testing of a new malaria vaccine on human subjects have begun, Inhabitat reports. The vaccine, called the PfSPZ vaccine, was developed by researchers at Sanaria.
Image courtesy of FreeDigitalPhotos.net
In the first human-based trial, six individuals were injected with the PfSPZ vaccine before being subjected to the bite of mosquitoes infected with malaria. All have shown to be fully immune to the disease.
Read more on Inhabitat here.
Related
Medicines for Malaria Venture and Africa CDC sign MoU to support African manufacturers
Natalie Grover 28 Dec 2022
Vaccine group invites African states to apply for malaria shot support
Jennifer Rigby and Mark Heinrich 21 Jul 2022
Kenya introduces anti-malaria vaccine
16 Sep 2019
Novel approach brings African scientists closer to a malaria vaccine
Faith Osier 7 Nov 2018
Hunt to eradicate drug-resistant diseases
10 Apr 2015
AIDS drug also offers protection against malaria, study finds
Denise L Meyer 22 Dec 2014
